Furthermore, the expression of myostatin, a muscle growth suppressor acting on both the protein synthesis and protein breakdown pathways, is unchanged or increased in atrophied COPD muscle compared with control muscle [3–5]. This evidence concerns the gene MSTN and chronic obstructive pulmonary disease.